Arrow International
Arrow International reports 13% increase in sales
Published in Lab Business Week, November 5th, 2006
Net sales for the fourth quarter of fiscal year 2006 increased 13.0% to $129.2 million from $114.3 million in the fourth quarter of fiscal year 2005 reflecting strong demand for the company's products in international markets and the U.S.
As previously reported, gross profit in last year's fourth quarter was reduced by a provision of $12.4 million for excess inventory and the write-off of $2.4 million of equipment no longer in use, which was offset by an increase in gross profit of $3.5 million for the correction of fixed asset lives....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2006-11-05)
More Articles from Lab Business Week
- Accentia Biopharmaceuticals
Accentia enters into definitive deal for a $25 million financing - Acorda Therapeutics
Acorda Therapeutics announces $31.5 million financing - Affinergy
Affinergy awarded $1.8 million grant for implant coatings - Auriga Laboratories
Auriga reports revenue guidance forecast of $26.4 million - Avant Immunotherapeutics
Avant Immunotherapeutics receives grant to develop, manufacture Ty800 with VitriLife - BioSyntech
BioSyntech announces conditional approval for listing on the Toronto Stock Exchange - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
